Literature DB >> 19284479

Expression of reticulon 3 in Alzheimer's disease brain.

H Kume1, Y Konishi, K S Murayama, F Kametani, W Araki.   

Abstract

AIMS: Reticulon 3 (RTN3), a member of the reticulon family of proteins, interacts with the beta-secretase, beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1), and inhibits its activity to produce beta-amyloid protein. The aim of the present study was to clarify the biological role of RTN3 in the brain and its potential involvement in the neuropathology of Alzheimer's disease (AD).
METHODS: We performed immunohistochemical and biochemical analyses using a specific antibody against RTN3 to investigate the expression and subcellular localization of RTN3 in control and AD brain tissue samples.
RESULTS: Western blot analysis revealed no significant differences in the RTN3 levels between control and AD brains. Immunohistochemical staining showed that RTN3 immunoreactivity was predominantly localized in pyramidal neurones of the cerebral cortex. The patterns of RTN3 immunostaining were similar in control and AD cerebral cortices, and senile plaques were generally negative for RTN3. Biochemical subcellular fractionation disclosed that RTN3 colocalized with BACE1 in various fractions, including the endoplasmic reticulum and the Golgi apparatus. Double-immunofluorescence staining additionally indicated that RTN3 was localized in both endoplasmic reticulum and Golgi compartments in neurones.
CONCLUSIONS: These results show that RTN3 is primarily expressed in pyramidal neurones of the human cerebral cortex and that no clear difference of RTN3 immunoreactivity is observable between control and AD brains. Our data also suggest that there is considerable colocalization of RTN3 with BACE1 at a subcellular level.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19284479      PMCID: PMC2930375          DOI: 10.1111/j.1365-2990.2008.00974.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  43 in total

1.  Extracellular release of BACE1 holoproteins from human neuronal cells.

Authors:  Kiyoko S Murayama; Fuyuki Kametani; Wataru Araki
Journal:  Biochem Biophys Res Commun       Date:  2005-10-13       Impact factor: 3.575

2.  The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice.

Authors:  Masashi Asai; Chinatsu Hattori; Nobuhisa Iwata; Takaomi C Saido; Noboru Sasagawa; Beáta Szabó; Yasuhiro Hashimoto; Kei Maruyama; Sei-ichi Tanuma; Yoshiaki Kiso; Shoichi Ishiura
Journal:  J Neurochem       Date:  2005-12-08       Impact factor: 5.372

3.  Reticulons RTN3 and RTN4-B/C interact with BACE1 and inhibit its ability to produce amyloid beta-protein.

Authors:  Kiyoko S Murayama; Fuyuki Kametani; Shinya Saito; Hideaki Kume; Haruhiko Akiyama; Wataru Araki
Journal:  Eur J Neurosci       Date:  2006-09-08       Impact factor: 3.386

4.  Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.

Authors:  Oded Singer; Robert A Marr; Edward Rockenstein; Leslie Crews; Nicole G Coufal; Fred H Gage; Inder M Verma; Eliezer Masliah
Journal:  Nat Neurosci       Date:  2005-08-28       Impact factor: 24.884

Review 5.  Reticulon proteins: emerging players in neurodegenerative diseases.

Authors:  R Yan; Q Shi; X Hu; X Zhou
Journal:  Cell Mol Life Sci       Date:  2006-04       Impact factor: 9.261

6.  Brain site-specific gene expression analysis in Alzheimer's disease patients.

Authors:  T Yokota; M Mishra; H Akatsu; Y Tani; T Miyauchi; T Yamamoto; K Kosaka; Y Nagai; T Sawada; K Heese
Journal:  Eur J Clin Invest       Date:  2006-11       Impact factor: 4.686

7.  BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions.

Authors:  Fiona M Laird; Huaibin Cai; Alena V Savonenko; Mohamed H Farah; Kaiwen He; Tatyana Melnikova; Hongjin Wen; Hsueh-Cheng Chiang; Guilian Xu; Vassilis E Koliatsos; David R Borchelt; Donald L Price; Hey-Kyoung Lee; Philip C Wong
Journal:  J Neurosci       Date:  2005-12-14       Impact factor: 6.167

8.  Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice.

Authors:  Diana Dominguez; Jos Tournoy; Dieter Hartmann; Tobias Huth; Kim Cryns; Siska Deforce; Lutgarde Serneels; Ira Espuny Camacho; Els Marjaux; Katleen Craessaerts; Anton J M Roebroek; Michael Schwake; Rudi D'Hooge; Patricia Bach; Ulrich Kalinke; Dieder Moechars; Christian Alzheimer; Karina Reiss; Paul Saftig; Bart De Strooper
Journal:  J Biol Chem       Date:  2005-06-29       Impact factor: 5.157

9.  Tissue specificity and regulation of the N-terminal diversity of reticulon 3.

Authors:  Franck Di Scala; Luc Dupuis; Christian Gaiddon; Marc De Tapia; Natasa Jokic; Jose-Luis Gonzalez de Aguilar; Jean-Sébastien Raul; Bertrand Ludes; Jean-Philippe Loeffler
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

10.  Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.

Authors:  Matthew J Chiocco; Laura Shapiro Kulnane; Linda Younkin; Steve Younkin; Geneviève Evin; Bruce T Lamb
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

View more
  11 in total

1.  Widespread distribution of reticulon-3 in various neurodegenerative diseases.

Authors:  Jonathon E Heath; Sandra L Siedlak; Xiongwei Zhu; Hyoung-Gon Lee; Akanksha Thakur; Riqiang Yan; George Perry; Mark A Smith; Rudy J Castellani
Journal:  Neuropathology       Date:  2010-12       Impact factor: 1.906

2.  RTN/Nogo in forming Alzheimer's neuritic plaques.

Authors:  Marguerite Prior; Qi Shi; Xiangyou Hu; Wanxia He; Allan Levey; Riqiang Yan
Journal:  Neurosci Biobehav Rev       Date:  2010-02-06       Impact factor: 8.989

3.  Development of a specific ELISA to measure BACE1 levels in human tissues.

Authors:  Amanda Gonzales; Boris Decourt; Aaron Walker; Rachel Condjella; Hikmet Nural; Marwan N Sabbagh
Journal:  J Neurosci Methods       Date:  2011-08-25       Impact factor: 2.390

4.  Proteolytic control of neurite outgrowth inhibitor NOGO-A by the cAMP/PKA pathway.

Authors:  Maria Sepe; Luca Lignitto; Monia Porpora; Rossella Delle Donne; Laura Rinaldi; Giuseppe Belgianni; Gianna Colucci; Ornella Cuomo; Davide Viggiano; Antonella Scorziello; Corrado Garbi; Lucio Annunziato; Antonio Feliciello
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

5.  Impact of RTN3 deficiency on expression of BACE1 and amyloid deposition.

Authors:  Qi Shi; Yingying Ge; Md Golam Sharoar; Wanxia He; Rong Xiang; Zhuohua Zhang; Xiangyou Hu; Riqiang Yan
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

Review 6.  The role of reticulons in neurodegenerative diseases.

Authors:  Valerio Chiurchiù; Mauro Maccarrone; Antonio Orlacchio
Journal:  Neuromolecular Med       Date:  2013-11-12       Impact factor: 3.843

7.  Revelation of Pivotal Genes Pertinent to Alzheimer's Pathogenesis: A Methodical Evaluation of 32 GEO Datasets.

Authors:  Hema Sree Gns; Saraswathy Ganesan Rajalekshmi; Raghunadha R Burri
Journal:  J Mol Neurosci       Date:  2021-10-19       Impact factor: 2.866

8.  Exploring the contribution of estrogen to amyloid-Beta regulation: a novel multifactorial computational modeling approach.

Authors:  Thomas J Anastasio
Journal:  Front Pharmacol       Date:  2013-03-01       Impact factor: 5.810

9.  RTN3 Regulates the Expression Level of Chemokine Receptor CXCR4 and is Required for Migration of Primordial Germ Cells.

Authors:  Haitao Li; Rong Liang; Yanan Lu; Mengxia Wang; Zandong Li
Journal:  Int J Mol Sci       Date:  2016-04-08       Impact factor: 5.923

Review 10.  Role of Endoplasmic Reticulum-Associated Proteins in Flavivirus Replication and Assembly Complexes.

Authors:  Hussin A Rothan; Mukesh Kumar
Journal:  Pathogens       Date:  2019-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.